Frequency, risk factors, prognosis value of HIV associated anaemia in adult in Mali;Fréquence, facteurs de risque et valeur pronostique de l'anémie associée au VIH/sida chez l'adulte au Mali

Bulletin de la Societe de Pathologie Exotique

Volumn 96, Issue 2, 2003, Pages 123-127

  Diallo, D A ^a,b   Baby, M ^a,b   Dembele M ^a   Keita A ^a   Sidibe A T ^a   Cisse I Ah ^a   Diop, C T ^a   Maiga I I ^a   Traore A K ^a   Traore H A ^a  

^a Hopital National du Point G   (Mali)

^b Fac Med Pharm d'O   (Mali)

Author keywords

Adult; Anaemia; Bamako; HIV; Hospital; Mali; Prognosis; Risk factor; Sub Saharan Africa

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BONE MARROW DEPRESSION; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE TRANSFUSION; ERYTHROPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTOPENIA; MORBIDITY; MORTALITY; PROGNOSIS; RISK FACTOR; THROMBOCYTOPENIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; ANEMIA; ERYTHROCYTE TRANSFUSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MALI; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS;

EID: 0037705332     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ABRAMS DI, STEINHART C & FRASCINO R - Epoetin alfa therapy for anaemia in HIV-infected patients: impact on quality of life. Int J STD AIDS, 2000, 11, 659-665.
2. ANGLATET X, CHENE G, ATTIA A,TOURÉ S, LAFONT S et al.- Early chemoprophylaxis with Trimethoprim-Sulfamethoxazole for HIV-1-infected Adults in Abidjan, Côte d'Ivoire: a Randomised Trial. Cotrimo-CI study Group. Lancet, 1999, 353, 1463-1468.
3. BAGAYOKO D - Etude critique de l'activité d'un service de médecine interne à Bamako. Thèse Méd, Bamako, 1993, 22.
4. BROOK MG, AILES H, HARRISON C, ROWNTREE C & MILLER RF Diagnostic utility of bone marrow sampling in HIV positive patients. Genitourinary Med, 1997, 73, 117-1121.
5. DURAND B, MOULIN N & GUIBAUD S - Anémie et infection par le virus de l'immunodéficience humaine. Edition pharmaceutique, 1996, 47, 11-16.
6. FARINAS CA - Anemia in Hiv disease, Rita Neews, 1998, 4, 11-12.
7. FISCHL M, GALPIN JE & LEVINE JD - Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med, 1990, 322, 1488-1492.
8. FRICKHOFEN N, ABKOWITZ JL & SAFFORD M - Persistent B19 Parvovirus infection in patients infected with human immunodeficiency virus type 1 (VIH-1): a treatable cause of anemia in AIDS. Ann Intern Med, 1990, 113, 926-933.
9. GEISSLER R, OHMAN OG & EDER M - Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of VIH. Ann Hematol, 1991, 62, 151-155.
10. IFURU O - Maximizing response to erythropoietin in treating HIV-associated anemia. Cleve Clin J Med, 2001, 68, 643-648.
11. KANOUTÉ F - Aspects cliniques et paracliniques du SIDA à Bamako. Thèse Méd, Bamako, 1991, 11.
12. KARCHER DS & FROST AR - The bone marrow in human immunodeficiency virus (VIH) related disease. Am J Clin Pathol, 1991, 95, 63-71.
13. KREUZER KA & ROKSTROH JK - Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol, 1997, 75, 179-187.
14. MOORE RD, KERULY JC & CHAISON RE - Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retroviral, 1998, 19, 29-33.
15. MYLONAKIS E, DICKINSON BP, MILENO MD, FLANIGANT, SCHIFFMAN FJ et al.- Persistent parvovirus B19 related anemia of seven years' duration in HIV-infected patient: complete remission associated with highly active antiretroviral therapy. Am J Hematol, 1999, 60, 164-166.
16. OMS - Case definition for AIDS surveillance in adults and adolescents. Rel épidémiol hebd, 1994, 69, 273-275.
17. PICHARD E, GUINDO D, GROSSETETE G, FOFANA Y, MAÏGA YI et al.- L'infection par le virus de l'immunodéficience humaine (HIV) au Mali. Méd Trop, 1988, 48, 345-349.
18. SATHE SS, GASCONE P, LOW, PINTO R & REICHMAN LB Severe anemia is an important negative predictor for survival with disseminated Mycobacterium avium intracellulare in acquired immunodeficiency syndrome. Am Rev Respir Dis, 1990, 142, 1036-1042.
19. SIPSAS NV, KOKORI SI, IOANNIDIS JP, KYRIAKI D, TZIOUFAS AG & KORDOSSIS T. Circulating autoantibodies to erythropoietine are associated with human immunodeficiency virus type 1-related anemia. J Infect Dis, 1999, 180, 2044-2047.
20. STETOR SR, RAUSCH JW, GUO MJ, BURNHAM JP, BOONE LR et al.- Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome. Biochemistry, 1999, 38, 3656-3667.
21. SULLIVAN PS, HANSON DL, CHU SY, JONES JL & WARD JW - Epidemiology of anemia in human immunodeficiency virus (HIV) - infected persons: result from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood, 1998, 91, 301-308.
22. VOLBERDING P - Consensus statement: anemia in HIV infection-current trends, treatment options, and practice strategies. Anemia in HIV Working Group. Clin Ther, 2000, 22, 1004-1020.
23. WIKTOR SZ, SASSAN-MOROKO M, GRANT AD, ABOUYA L, KARON JM et al.- Efficacy of Trimethoprim-sulfamethoxazole Prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomized Controlled Trial. Lancet, 1999, 353, 1469-1475.